Arterial and venous thrombosis and normal response to streptokinase treatment in a young patient with severe Hageman factor deficiency

Acta Haematologica
P HellsternE Wenzel

Abstract

The case history of a patient with severe factor XII deficiency (factor XII activity and concentration below 1%) is described. The case reported gives further evidence that factor XII deficiency leads to a prolonged euglobulin lysis time. This might be a risk factor indicating a proneness to thromboembolic events. The young man suffered from arterial and venous thrombosis, and underwent lower extremity amputation without bleeding complications, as well as thrombolytic therapy to save the other leg. There was a normal response to streptokinase, heparin, and phenprocoumon treatment.

Citations

Sep 1, 1992·Clinical Rheumatology·P DisdierP J Weiller
Jul 25, 1992·Lancet·L SpeicherF J Kunz
Dec 27, 2005·Neurologia Medico-chirurgica·Wojciech KasperaAntoni Stadnicki
Mar 12, 2004·American Journal of Ophthalmology·Claudia KuhliLars-Olof Hattenbach
Jun 1, 1990·Journal of the American Academy of Dermatology·C P Samlaska, W D James
Feb 26, 2008·American Journal of Reproductive Immunology : AJRI·Hidehiko MatsubayashiMikio Mikami
Apr 1, 1991·Baillière's Clinical Haematology·V S BlanchetteC Turner
May 1, 1988·Australian and New Zealand Journal of Medicine·B G Firkin
Jan 29, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A GirolamiC Bertolo
Oct 22, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A GirolamiM L Randi
Aug 22, 2017·Frontiers in Medicine·Fabrício Simão, Edward P Feener
Jul 25, 2021·Journal of Clinical Medicine·Adrianna MarcinkowskaMarcin Rozalski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.